These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 9632141)
1. FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells. Johnson MR; Valentine C; Basilico C; Mansukhani A Oncogene; 1998 May; 16(20):2647-56. PubMed ID: 9632141 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: lack of correlation between inhibition of cell growth and MAP kinase activation. Wieder R; Fenig E; Wang H; Wang Q; Paglin S; Menzel T; Gabrilove J; Fuks Z; Yahalom J J Cell Physiol; 1998 Dec; 177(3):411-25. PubMed ID: 9808150 [TBL] [Abstract][Full Text] [Related]
3. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells. Gooch JL; Herrera RE; Yee D Cell Growth Differ; 2000 Jun; 11(6):335-42. PubMed ID: 10910100 [TBL] [Abstract][Full Text] [Related]
4. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
5. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells. Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849 [TBL] [Abstract][Full Text] [Related]
6. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells. Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955 [TBL] [Abstract][Full Text] [Related]
7. Involvement of MAP kinase-independent protein kinase C signaling pathway in the EGF-induced p21(WAF1/Cip1) expression and growth inhibition of A431 cells. Toyoda M; Gotoh N; Handa H; Shibuya M Biochem Biophys Res Commun; 1998 Sep; 250(2):430-5. PubMed ID: 9753647 [TBL] [Abstract][Full Text] [Related]
8. MDA468 growth inhibition by EGF is associated with the induction of the cyclin-dependent kinase inhibitor p21WAF1. Xie W; Su K; Wang D; Paterson AJ; Kudlow JE Anticancer Res; 1997; 17(4A):2627-33. PubMed ID: 9252692 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation. Giani C; Casalini P; Pupa SM; De Vecchi R; Ardini E; Colnaghi MI; Giordano A; Ménard S Oncogene; 1998 Jul; 17(4):425-32. PubMed ID: 9696035 [TBL] [Abstract][Full Text] [Related]
10. Basic fibroblast growth factor mediated growth inhibition in breast cancer cells is independent of ras signaling pathway. Fenig E; Szyper-Kravitz M; Yerushalmi R; Lahav M; Beery E; Wasserman L; Gutman H; Nordenberg J Oncol Rep; 2002; 9(4):875-7. PubMed ID: 12066225 [TBL] [Abstract][Full Text] [Related]
11. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of Akt activity contributes to the growth arrest induced by FGF in chondrocytes. Priore R; Dailey L; Basilico C J Cell Physiol; 2006 Jun; 207(3):800-8. PubMed ID: 16523491 [TBL] [Abstract][Full Text] [Related]
13. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Yin F; Giuliano AE; Law RE; Van Herle AJ Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771 [TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines. Mohamood AS; Gyles P; Balan KV; Hollis VW; Eckberg WR; Asseffa A; Han Z; Wyche JH; Anderson WA J Submicrosc Cytol Pathol; 1997 Jan; 29(1):1-17. PubMed ID: 9066137 [TBL] [Abstract][Full Text] [Related]
16. The induction and activation of STAT1 by all-trans-retinoic acid are mediated by RAR beta signaling pathways in breast cancer cells. Shang Y; Baumrucker CR; Green MH Oncogene; 1999 Nov; 18(48):6725-32. PubMed ID: 10597280 [TBL] [Abstract][Full Text] [Related]
17. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095 [TBL] [Abstract][Full Text] [Related]
18. Protein kinase C-dependent and -independent pathways of signal transduction in prostate cancer cells: fibroblast growth factor utilization of a protein kinase C-independent pathway. Hrzenjak M; Shain SA Cell Growth Differ; 1995 Sep; 6(9):1129-42. PubMed ID: 8519690 [TBL] [Abstract][Full Text] [Related]
19. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306 [TBL] [Abstract][Full Text] [Related]
20. TGF-beta regulates differentially the proliferation of fetal and adult human skin fibroblasts via the activation of PKA and the autocrine action of FGF-2. Giannouli CC; Kletsas D Cell Signal; 2006 Sep; 18(9):1417-29. PubMed ID: 16361081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]